Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|January 11, 2025
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 InhibitorsMagdi Awadalla Mohamed, Mohamed Khalid Alhaj Awadalla, Malik Suliman Mohamed, et al.
Acta Crystallographica. Section E, Structure Reports Online|August 21, 2012
2-(2,3-Dimethyl-anilino)benzohydrazideHoong-Kun Fun, Tze Shyang Chia, Tilal Elsaman, et al.
Journal of Infection in Developing Countries|December 1, 2024
Assessment of perspectives, knowledge and attitude about antibiotic use and resistance in Sudanese populationMalik Suliman Mohamed, Mohamed Khalid, Mona Timan Idriss, et al.
Pakistan Journal of Pharmaceutical Sciences|March 1, 2022
De novo design of novel spike glycoprotein inhibitors using e-pharmacophore modeling, molecular hybridization, ADMET, quantum mechanics and molecular dynamics studies for COVID-19Abdulrahim A Alzain, Abdalla Ismail, Mohammed Fadlelmola, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 20, 2019
Human cytomegalovirus-encoded MicroRNAs: A master regulator of latent infectionAbualgasim Elgaili Abdalla, Mahjoob Osman Mahjoob, Khalid Omer Abdalla Abosalif, et al.
Molecules (Basel, Switzerland)|December 7, 2011
Schiff bases of indoline-2,3-dione: potential novel inhibitors of Mycobacterium tuberculosis (Mtb) DNA gyraseTarek Aboul-Fadl, Hatem A Abdel-Aziz, Mohammed K Abdel-Hamid, et al.
Frontiers in Immunology|December 12, 2025
Interleukin-32: a Pandora's box in human immunodeficiency virus infectionAbualgasim Elgaili Abdalla, Emad Manni, Tilal Elsaman, et al.
Biological & Pharmaceutical Bulletin|July 10, 2015
Synthesis, in Vitro and in Silico Studies of Some Novel 5-Nitrofuran-2-yl Hydrazones as Antimicrobial and Antitubercular AgentsHatem Abdel-Kader Abdel-Aziz, Wagdy Mohamed Eldehna, Mohamed Fares, et al.
Pageof 4